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Detailed Explanation of Updated Techniques
The potential for MSλD is given by
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V (xsi,xt j)+VBias({λ}) , (S1)
where λsi is the alchemical coordinate for mutation i at site s, M is the number of mutation sites, Ns
is the number of mutants (including native) at a particular site s, V (a,b) is the interaction energy
between particles in groups a and b, where x0 is the group of environment atoms common to all
systems and xsi is the group of atoms unique to mutant i at site s, and VBias({λ}) is a multidimen-
sional biasing potential to facilitate sampling in λ space.
The previous set of biasing potentials
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s
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∑
i
Ns
∑
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ωsi,s jλs jλsi/(λsi+α) , (S4)
with α = 0.017, were initially optimized to flatten alchemical free energy landscapes observed
with hard-core interactions. An additional biasing potential of the form
VSkew =
M
∑
s
Ns
∑
i
Ns
∑
j 6=i
χsi,s jλs j(1− exp(−λsi/σ)) , (S5)
with σ = 0.18, was found to give improved fits to free energy profiles obtained with soft-core
interactions. The previous flattening algorithm was effective in optimizing parameters in Equations
S2-S4, but had been carefully designed to handle a variety of special cases on an individual basis.
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Consequently, it was not easily modified to accommodate additional biasing potentials such as
Equation S5.
In the present work a more generalizable WHAM-based least-squares approach was used to
learn biasing potential parameters to flatten the landscape. Flattening consists of several dozen
rounds of very short simulations with iterative updates to the biasing potential parameters φsi,
ψsi,s j, χsi,s j, and ωsi,s j. During parameter optimization, recent trajectories are combined using
WHAM,1 and 1D free energy profiles are computed along λsi as well as λsi/(λsi+λs j) such that
(λsi + λs j) > 0.8 as before, but with 400 bins from 0 to 1. An additional 2D profile on λsi and
λs j with 20 bins in each direction is also computed. The entropy of the implicit constraints is
subtracted from the free energy profiles as before. A scoring function for proposed changes in
parameters at each site s is constructed as
E =
Profiles
∑
p
Bins
∑
b
wpb
2
(Gpb+∆Gpb− G¯p)2 +
Biases
∑
i
k
2γ02
∆γi2 (S6)
∆Gpb =
Biases
∑
i
∂Gpb
∂γi
∆γi , (S7)
and the scoring function is minimized at each site s independently. Here, γi runs over all bi-
asing potential parameters in the set {φsi,ψsi,s j,χsi,s j,ωsi,s j}. Regularization parameters are k =
1( kcal/mol)2, with γ0 set to φ0 = 2 kcal/mol, ψ0 = 8 kcal/mol, χ0 = 2 kcal/mol, ω0 = 1 kcal/mol
depending on the type of parameter. For 1D λsi profiles, the weight wpb = 100 for the last bin or
wpb = 1 otherwise, to discourage sharp charges in the free energy near the λsi = 1 endpoint which
subsequently result in undersampling or oversampling (trapping) at that endpoint. The weight
wpb = 2/(Ns−1) for all bins b of profiles p so that the total weight of all Ns(Ns−1)/2 transition
profiles is constant relative to the weight of the Ns different λsi profiles. The free energy terms Gpb
and ∂Gpb/∂γi are calculated with WHAM from the states sampled during recent simulations. The
first term of Equation S6 assesses landscape flatness and predicts the effects of changes in biasing
parameters on landscape flatness through the linear approximation of ∆Gpb, and the second reg-
ularization term prevents overfitting between subsequent flattening runs. The scoring function in
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Equation S6 is minimized with G¯pb and ∆γi as free parameters using least squares. If any parame-
ter at site s changes more than 1.5 times its respective limit of φ0, ψ0, χ0, or ω0, the changes in all
parameters are scaled uniformly such that the largest change is 1.5 times φ0, ψ0, χ0, or ω0. This
flattening algorithm can be easily generalized to other biasing potentials as needed, and converges
comparably with the old algorithm using the more limited set of biasing potentials.
In the previous version of ALF,2 an initial estimation of the fixed biases was performed, but
was omitted in the present work because it added complexity without saving much time. As before,
50 cycles of optimization were run with 100 ps of equilibration and 100 ps of sampling, followed
by 10 cycles of optimization with 100 ps of equilibration followed by 1 ns of sampling. Previously,
optimization for 100 ps and 1 ns runs included sampling from the last 10 and 6 cycles respectively
in WHAM-based estimates of free energy profiles, but it was noted that convergence was more
rapid using only the last 5 cycles as poorly sampled simulations could not misguide parameter
estimation for as many cycles. We observed that biasing potentials at the end of the 1 ns cycles
were still suboptimal for some of the more slowly converging sites (e.g. A42, A98, and M102),
so an additional phase with three cycles of 2 of ns equilibration followed by 5 ns of sampling
combining data from the last 3 cycles was added to the protocol for all sites. For production, 5
independent simulations were run for 40 ns each.
It was observed that often some substituents stopped being sampled after the system had re-
laxed, therefore the first quarter of all production runs was discarded for equilibration. If sampling
was poor during the remainder of production, landscape flattening parameters were reestimated
and an additional one to three rounds of production were run, until all substituents were being
sampled efficiently during the remainder of production. (See Table S2 for details.) A physical
state of the system is achieved when one λ per site is equal to 1, and all the others are 0. The
free energy of the physical states can be estimated by binning states for which all sites have one
λ greater than λc = 0.99, Boltzmann inverting the populations, and subtracting the biasing po-
tentials.2 Results from different independent trials and replicas of the final production run were
combined using WHAM,1 free energies were computed from endpoint populations with a λ cutoff
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of 0.99,2,3 and uncertainties were computed from bootstrap analysis.2
Table S1: Optimal VB-REX Parameters
Sites Ba N Replicas Flat Replicab
1 1.6 3 2
3 1.0 4 2
4 0.8 4 2
5 0.6 6 3
ain (kcal/mol)
bThe (one indexed) replica whose energy landscape is flattened
Inspired by BP-REX,4 a new form of biasing potential replica exchange on the variable biases
(VB-REX) was implemented to encourage interconversion of side chains in low replicas, and end-
point sampling in high replicas. This was achieved by changing the biasing potential parameters
between neighboring replicas by ∆ψsi,s j = 2B and ∆ωsi,s j = 0.5B for all si-s j combinations, in or-
der to change the barrier height by B. Parameters vary with the number of sites (Table S1), where B
is tuned to optimize exchange rates, while the number of replicas and the replica targeted by ALF
are tuned to sample primarily physical endpoint states in the final replica. VB-REX simulations
used it during both sampling and production, and production simulations were only sampled for
20 ns due to faster convergence. For the 5 mutation site system, even the small 1.8 kcal/mol barrier
in the sixth replica relative to the third replica was adequate to increase the sampling of approxi-
mately physical states (λ > 0.99 at all sites) by about two orders of magnitude. Optimal VB-REX
parameters elsewhere will depend on the number of sites and mutations.
Three different electrostatic models were considered in this work: FSHIFT, FSWITCH, and
PME. In preliminary simulations, FSHIFT showed poorer correlation with experiment and roughly
0.5 kcal/mol greater RMSE, so only FSWITCH and PME results are reported. FSHIFT subtracts a
constant from the electrostatic force so that it is zero at the cutoff while FSWITCH multiplies the
electrostatic force by a function that decays smoothly from one to zero within a narrow range. The
electrostatic potential is then obtained by integrating the electrostatic force. See equations 6 and
9 in Reference 5. FSWITCH gives a smaller perturbation to electrostatics than FSHIFT, but both
neglect long range electrostatic effects, which are accounted for with PME.
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PME splits the electrostatic potential into a short range piece accurately calculated with cutoffs
and a smooth long range piece accurately calculated in Fourier space.6,7 Using PME in MSλD
simulations is not trivial, and we follow the approach of Jana Shen:8 the short range piece is scaled
according to Equation S1, while in the long range piece, the charges of an atom in substituent si are
scaled by λsi, which means the interaction between two atoms is scaled by the product of their λ ’s,
even if the atoms are in the same site or even the same substituent, (which would normally result in
a scaling of 0 or λ , respectively). PME exclusion terms were scaled by λsi for exclusions between
a side chain and the environment, λsiλt j for exclusions between sites, 0 for exclusions between
different side chains at the same site, and λsi2 for exclusions within the same side chain. While this
treatment alters the alchemical pathway between endpoints, the energy of the endpoints themselves
is not affected, so the results will be unaffected. Alchemical simulations involving a net change
in charge can result in serious artifacts.9–11 While corrections for these effects have been devised
for PME,12 they were not applied in the present work since only two of the considered mutants
involved a charge change. Application of these corrections is deferred until it can be tested more
systematically.
For FSWITCH simulations, the switching radius was 10 Å, the cutoff radius was 12 Å, and the
neighbor list radius was 15 Å. For PME simulations, the grid spacing was 1 Å, the interpolation
order was 6, κ was 0.32 Å−1, the switching radius (for van der Waals interactions) was 9 Å, the
cutoff radius was 10 Å, and the neighbor list radius was 12 Å.
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Convergence of Multisite Results
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Figure S1: Comparison of SSλD and MSλD results in the multisite systems. Dashed lines denote
y= x. Agreement in the 3 site system is good, suggesting sampling is well converged. Agreement
is poorer in the 4 site and 5 site systems, suggesting sampling or convergence issues in these
systems. RMS differences are roughly 0.5 kcal/mol or less, which is substantially smaller than the
deviations from experiment, suggesting that sampling is a small but non-negligible source of error.
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Flattening with Production Runs
Sometimes landscape flattening parameters derived from 5 ns simulations did not allow effective
sampling during the last three quarters of the production simulations. This occurs either because
insufficient sampling was obtained during the 5 ns flattening runs, possibly due to trapping in one
or more iterations, or because the system is not fully relaxed by the end of 5 ns. This was only
observed in the protein side of the thermodynamic cycle (∆GFolded(S1 → S2)); the pentapeptide
mimic of the unfolded ensemble converged rapidly and flattened efficiently (and did not require
VB-REX for the A42, A98, and M102).
There were fewer slowly converging sites in the multisite systems. The 3 site and 4 site systems
converged well with their initial biases. The 5 site system failed to sample a few sequences due to
the large sequence space and possible cooperative effects between mutations, but reoptimizing the
biases seemed unlikely to improve matters, so production was not used to reoptimize the biases for
any of the multisite systems.
When rerunning production several times due to poor sampling, it is possible to artificially im-
prove results by stopping after a production run that agrees well with experiment, but this inflates
agreement and is not possible in a prospective study. To avoid this pitfall, only ∆GFolded(S1→ S2)
and its statistical uncertainty were computed after a particular round of production. ∆∆GFolding(S1→
S2) was not computed, nor was it compared to experiment until after the biases were deemed ade-
quately converged.
Four measures of convergence were used for the biasing potential parameters. The statistical
uncertainty of ∆GFolded(S1→ S2) was computed from the simulation. If the statistical uncertainty
was above 0.5 kcal/mol, this indicated poor convergence. Since the results are especially sensitive
to the free energy of the reference sequence (the native sequence), the biases were judged uncon-
verged if the uncertainty of the reference sequence was above 0.3 kcal/mol. For the small number
of independent trials (5) is is possible to get serendipitously obtain roughly the same free energy
results from all trials even when the biases are poor. Therefore the changes in the fixed biases
∆φsi based on the current production run were also compared. If the range between the maximum
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and minimum ∆φsi was greater than roughly 3kT , this indicates the biases are unconverged, as the
ratio in sampling will be roughly 1:20 for this difference. Furthermore, the lower the minimum
of ∆φsi, (∆φs0 is always subtracted from ∆φsi so that the fixed bias of the reference sequence φs0
remains 0), the more difficult it will be to sample the reference sequence, so we sought to keep
this above −2kT . With these limits in mind, some sites are more difficult to sample, and one
must concede the sampling is not going to improve upon further bias optimization, while other
sites sample very easily, and one more round of production could substantially improve statistical
uncertainty even though the criteria are met, therefore bias optimization still requires some human
oversight. Reasoning for decisions to reoptimize biases is provided in the notes column of Table
S2. All production runs started on iteration 64, after 50 rounds of 100 ps flattening, 10 rounds of 1
ns flattening, and 3 rounds of 5 ns flattening.
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Table S2: Bias Reoptimization with Production Runs
FSWITCH
System Iteration Ref Unca Max Unca Min ∆φsi Range ∆φsi Notes
V149 64 0.223 0.223 -0.78 1.44 Converged
M102 64 0.113 0.227 -1.83 1.83 Min ∆φsi bad
M102 65 0.222 0.241 -0.67 0.92 Converged
L99 64 0.130 0.170 -1.02 1.46 Converged
A98 64 0.571 0.712 -2.76 2.76 All bad
A98 65 0.229 0.734 -0.69 2.68 Reference sequence is better
A98 66 0.436 0.564 -1.62 2.65 All bad again
A98 67 0.186 0.465 -0.31 1.89 Converged: Range ∆φsi bad
A42 64 0.085 0.598 0.00 1.95 Range ∆φsi bad
A42 65 0.155 0.220 0.00 0.69 Converged
M106 64 0.047 0.047 -0.75 0.75 Converged
F153 64 0.166 0.271 -0.25 0.31 Converged
PME
System Iteration Ref Unca Max Unca Min ∆φsi Range ∆φsi Notes
V149 64 0.164 0.521 -1.23 1.44 Min ∆φsi and Max unc bad
V149 65 0.146 0.512 -0.43 0.90 Converged: Max unc bad
M102 64 nan nan -2.66 2.66 All bad
M102 65 nan nan -1.33 1.93 All bad
M102 66 0.877 1.083 -2.09 2.23 Improving
M102 67 0.273 0.336 -0.85 0.85 Converged
L99 64 0.061 0.195 -0.99 0.99 Converged
A98 64 0.165 0.315 -0.81 1.98 Range ∆φsi bad
A98 65 0.653 0.670 -0.95 2.84 Range ∆φsi worse
A98 66 0.328 0.372 -0.93 1.72 Converged: Ref unc bad
A42 64 0.369 0.369 -1.02 1.54 Ref unc bad
A42 65 0.323 0.323 -1.05 1.05 Ref unc bad
A42 66 0.283 0.283 -0.44 0.58 Converged
M106 64 0.076 0.106 -0.23 0.23 Converged
F153 64 0.126 0.355 -0.23 0.81 Max unc could improve
F153 65 0.123 0.273 -0.62 0.68 Converged
aUnc is uncertainty
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Computational Efficiency
A direct estimation of the relative computational efficiencies of MSλD and FEP is difficult, either
in terms simulation time or CPU time. The central issue is that one can run either method for more
or less time, so a fair comparison requires simulations that obtain the same level of statistical preci-
sion on the same systems. Given the substantially lower efficiency of FEP, running the simulations
required for such a comparison is undesirable due to computational expense. Indeed, in another
large scale MSλD study, FEP controls on a small fraction of the systems studied with MSλD re-
quired far more computing resources than the entire MSλD study.13 That study concluded MSλD
was roughly 20-30 times more efficient in simulation time than FEP.
As a large scale study of FEP folding free energies, Reference 14 is the closest comparison
available, but direct comparison is not possible for two reasons. First, that study only cites their
accuracy relative to experiment, and makes no estimate of precision. Second, that study examined
mostly large to small mutations which converge more rapidly than the small to large mutations in
the present study. A related study, Reference 15 found that obtaining accurate predictions for small
to large mutations with tryptophan required 100 ns per window, or 20 times more sampling than
Reference 14 used. With these caveats, Reference 14 took 60 ns of simulation time (12 windows
of 5 ns each) for neutral mutations and 80 ns of simulation time (16 windows of 5 ns each) for
charge changing mutations, requiring an average of 65 ns per mutation.
In the present study, we made little attempt to optimize computational efficiency by minimizing
the amount of time spent in landscape flattening. Instead of trying to obtain comparable precision
with FEP in less time, we used a comparable amount of time to standard FEP studies and ob-
tained more accurate results with higher precision. We traded away the computational advantage
of MSλD to run longer simulations, which improved the precision and accuracy of our results, and
to run multiple independent trials, which enabled us to more robustly estimate statistical precision.
A set of 5 independent trials without VB-REX takes a total of 200 ns (40 ns each), and with VB-
REX takes 300 ns (20 ns each times three replicas). If these production runs were poorly sampled,
they could only be used to further optimize the biases, resulting in a large waste of simulation time
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that could have been saved with a more careful procedure. The total simulation time including
flattening for the single site mutants was 117 ns per mutation (3746 ns total) for FSWITCH sim-
ulations and 148 ns per mutation (4746 ns total) for PME simulations. Without flattening, both
methods took 53 ns per mutation (1700 ns total). It is worth noting that these times would be
divided by five if we had run no independent trials (Reference 14 ran no independent trials), that
the majority of the computational expense was focused on the three sites that were more difficult
to converge: A42, A98, and M102, and that the multisite simulations ran for substantially less
time per mutation. It should be emphasized that while Reference 14 and the present study used
comparable amounts of simulation time per mutation, this is not an indication of comparable com-
putational efficiency, as the present study obtained high accuracy results with high precision, while
Reference 14 obtained lower accuracy results of unknown precision.
Finally, the conversion from simulation time to CPU time is rather meaningless. Both FEP and
MSλD add very little computational overhead to standard MD simulations, so comparisons are
dominated by the efficiency of the molecular dynamics engine and the hardware used. Reference
14 simulations were run on a GTX780 GPU cluster while the present simulations were run on a
faster GTX980 cluster. The present simulations were run with the CHARMM molecular dynamics
engine, which has an efficient GPU implementation, but is still only half as fast as OpenMM.
Simulations on our cluster with our code require 1.3 hours per ns on a single GPU for a 72 Å box
in the folded ensemble, but an industrial application of MSλD would ideally involve more efficient
code that effectively scales to multiple GPUs and runs on the most recent hardware.
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Structural Analysis
In order to quantify structural relaxation within our simulations, crystal structures for each of the 7
sites16–24 were visually inspected to identify reaction coordinates that correlate with mutation. Re-
action coordinates were chosen from crystal structures rather than from the trajectories themselves
because thermal vibrations tend to obscure slower motions. If the reaction coordinates identified
in crystals are subsequently seen to correlate with λ in our simulations, then the autocorrelation
time in these reaction coordinates indicates the speed of structural relaxations that are necessary to
obtain converged estimates of free energy.
Site A42 is missing crystal structures for three of the six mutations considered, suggesting
structural disruption by some of the more aggressive mutations may be larger than what is observed
in the remaining three structures. Even the rather conservative mutation A42V displaces residues
S36-S44 rather substantially by wedging more steric bulk into the interface between these residues
and the rest of the protein. Because this motion is rather large and collective, two distances were
chosen as possible reaction coordinates: A42Cα -T34Cα and A42Cα -Y25Cα .
Site A98 was also missing structures for three of the mutants and exhibited large structural
variations. A98M showed especially large RMSD (1.10 Å) because of a change in the opening of
the cleft between the N terminal and C terminal lobes. Fitting only the C terminal lobe (residues
1-10 and 70-162) gave a somewhat lower RMSD of 0.58 Å. Increasing the size of the mutated side
chain seemed to force the Cα atom of A98 further out of the cavity the side chain occupied; this
was well captured by the A98Cα -T152Cα distance.
Site AL99 showed surprisingly little structural variation. The largest and smallest mutants,
L99A and L99F showed slight changes that would be expected for protein collapse around a
smaller side chain or protein displacement to to a larger side chain. For L99A, the side chain
of Y88 moves closer by 0.2 Å. For L99F, V103 and V111 move closer by about 0.3 Å, and the side
chain of L84 moves away by 0.5 Å. Though nothing moved very much, the distance L99Cα -L84Cγ
was selected for giving the largest variation.
Although there are several moving parts in the M102 mutations, it is surprising how little
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structural disruption there is for the buried charge in M102K. M102 is pulled more deeply into the
protein for both M102A and M102K, and F153 moves to meet it, so M102Cα -F153Cζ was chosen
as one of the distances. While M102K does not become solvent exposed, it results in the flip of
several dihedrals in M106. These result in substantial changes to the M102Cα -M106Cε distance,
so this was chosen as the second reaction coordinate. The net effect of these dihedral flips in M106
is to reposition M106Sδ directly against the amine of M102K. While M102K is still buried, this
interaction with a soft, polarizable sulfur atom may partially compensate for charge burial. The
lack of polarization in our forcefield as well as the generally poor treatment of S and P atoms in
fixed charge forcefields may partially account for our very large error in M102K.
M106 causes motion of M102Cα by up to 0.7 Å, however this motion is perpendicular to the
distance between M106 and M102, and thus poorly captured by a distance. M106L pulls the
M106Cα 0.6 Å deeper into the protein, so M106Cα -W138Cα was chosen as the reaction coordi-
nate.
V149 mutations are relatively simple. Smaller side chains pull the Cα atom into the pocket
formerly occupied by the side chain and larger side chains push it out. The V149Cα -N101Cα
distance captures this effect well.
F153 is similarly simple. Mutation away from the native F cause decreases in steric bulk,
and all pull the Cα atom into the vacated pocket by about 0.6 Å. F153Cα -L99Cα was chosen to
measure this effect.
The mean distance in the simulations for a particular mutation was calculated by averaging over
all frames for which λ of that mutation was greater than 0.99. Overall, the mean distance observed
in simulations agreed rather closely with the distance observed in the crystal structure (Table S3).
The distances were typically slightly larger in simulations by 0.1 to 0.2 Å due to thermal vibrations.
S and T mutants typically occupied more volume than expected from crystal structures, resulting
in 0.5 Åincreases in the relevant distance. All chosen distances exhibited correlation with λ for at
least some of the side chains during the simulations.
It is noteworthy that three of the four sites displaying slower autocorrelation decay (A42, A98,
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M102, and M153) were sites identified as requiring enhanced sampling with VB-REX. Further-
more, while VB-REX should accelerate structural relaxation in these systems, their relaxation was
still slower than the remaining systems. The autocorrelation times further underline the fact that
while VB-REX was likely sufficient for A42 and M102, more aggressive sampling techniques are
needed to sample A98 well, due to its very slow autocorrelation decay.
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Table S3: Single Site Structural Analysis
AA XTAL XTAL BB RMSD XTAL Distance Mean Sim. Dist. Corr. (λ & Dist.)
A42: (A42Cα -T34Cα / A42Cα -Y25Cα )
A 1l63 0.00 5.91 / 6.22 5.93 / 6.77 -0.16 / -0.22
F —- —- —- / —- 6.22 / 7.02 -0.11 / -0.14
I —- —- —- / —- 6.63 / 7.71 0.20 / 0.25
L —- —- —- / —- 6.42 / 7.79 0.06 / 0.28
S 206l 0.12 5.85 / 6.43 6.11 / 6.85 -0.07 / -0.15
V 1qtb 0.24 6.46 / 7.00 6.48 / 7.30 0.17 / 0.12
A98: (A98Cα -T152Cα )
A 1l63 0.00 6.32 6.52 -0.08
C 1qsb 0.23 7.10 7.10 0.06
F —- —- —- 8.57 0.18
I —- —- —- 7.48 0.03
L 1qs5 0.32 7.70 7.99 0.20
M 1qth 1.10 7.46 7.49 0.05
S 125l 0.11 6.51 7.05 -0.34
V 1qs9 0.17 7.16 7.31 -0.06
W —- —- —- 8.36 0.15
L99: (L99Cα -L84Cγ )
L 1l63 0.00 8.25 8.36 -0.13
A 1l90 0.10 8.30 8.50 -0.06
F 1l91 0.14 8.94 9.07 0.54
I 1l92 0.10 8.29 8.06 -0.31
M 1l93 0.10 8.52 8.67 -0.02
V 1l94 0.12 8.07 8.12 -0.29
M102: (M102Cα -F153Cζ / M102Cα -M106Cε )
M 1l63 0.00 6.76 / 4.22 6.98 / 5.11 0.24 / -0.36
A 222l 0.18 6.24 / 5.01 6.40 / 4.76 -0.15 / -0.43
K 1l54 0.15 6.37 / 7.14 6.67 / 7.51 -0.08 / 0.64
M106: (M106Cα -W138Cα )
M 1l63 0.00 8.71 8.79 0.14
K 231l 0.20 8.75 8.39 -0.17
L 234l 0.14 8.38 8.61 0.03
V149: (V149Cα -N101Cα )
V 1l63 0.00 7.64 7.78 -0.19
C 1g07 0.12 7.66 7.95 -0.05
I 1g0q 0.16 7.90 7.95 -0.06
M 1cv6 0.15 8.19 8.35 0.31
S 1g06 0.15 7.46 8.00 0.02
T 126l 0.12 7.51 8.03 0.03
F153: (F153Cα -L99Cα )
F 1l63 0.00 8.45 8.62 0.40
A 1l85 0.22 7.77 7.46 -0.36
I 1l86 0.25 8.06 8.09 0.13
L 1l87 0.15 8.15 7.50 -0.22
M 1l88 0.17 7.94 7.97 0.03
V 1l95 0.28 8.01 8.14 0.13
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Table S4: Single Site Folding Free Energies
AA Experiment FSWITCH PME
A42
A 0.00 0.00±0.17 0.00±0.28
F 3.60 5.12±0.23 4.00±0.13
I 3.10 6.26±0.22 5.40±0.23
L 3.40 6.71±0.22 5.70±0.25
S 2.30 3.74±0.10 3.73±0.13
V 2.70 4.70±0.05 4.78±0.10
A98
A 0.00 0.00±0.19 0.00±0.33
C 1.00 1.40±0.17 2.51±0.35
F 5.90 6.19±0.37 6.66±0.24
I 4.90 5.37±0.20 4.31±0.32
L 4.30 4.90±0.25 5.01±0.17
M 3.20 2.51±0.46 2.10±0.21
S 2.50 2.36±0.22 2.34±0.37
V 3.20 4.09±0.11 3.20±0.37
W 5.70 8.82±0.26 7.04±0.28
L99
L 0.00 0.00±0.14 0.00±0.06
A 5.00 6.97±0.08 6.46±0.09
F 0.40 0.20±0.17 −0.00±0.11
I 1.40 3.21±0.17 2.88±0.20
M 0.70 1.16±0.15 0.89±0.08
V 2.30 4.44±0.17 3.95±0.17
M102
M 0.00 0.00±0.21 0.00±0.26
A 2.90 3.11±0.23 3.41±0.33
K 6.90 10.85±0.12 13.49±0.12
M106
M 0.00 0.00±0.06 0.00±0.08
K 3.40 2.98±0.04 4.09±0.11
L -0.50 −0.31±0.03 −0.32±0.04
V149
V 0.00 0.00±0.23 0.00±0.15
C 2.20 1.89±0.09 1.27±0.17
I 0.10 0.73±0.20 −0.47±0.12
M 2.80 3.03±0.18 1.48±0.16
S 4.40 6.31±0.25 4.82±0.51
T 2.80 3.46±0.13 2.70±0.32
F153
F 0.00 0.00±0.17 0.00±0.13
A 3.50 3.64±0.28 3.80±0.27
I 0.50 −0.03±0.11 0.42±0.04
L -0.20 −1.68±0.18 −1.26±0.20
M 0.80 −1.79±0.15 −1.35±0.09
V 1.80 1.71±0.14 2.24±0.05
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Table S5: 3 Site System Folding Free Energies
AA Experiment FSWITCH PME
IIL 0.00 0.00±0.12 0.00±0.05
IIM 2.00 2.94±0.11 2.65±0.10
IML 3.10 3.85±0.14 3.91±0.04
IMM 3.05 6.21±0.12 5.97±0.07
MIL 2.20 0.92±0.16 1.01±0.08
MIM 2.41±0.14 2.36±0.12
MML 4.53±0.16 4.40±0.09
MMM 3.30 5.45±0.15 5.06±0.12
Table S6: 4 Site System Folding Free Energies
AA Experiment FSWITCH PME
LMVF 0.00 0.00±0.23 0.00±0.15
LMVL -0.20 −0.98±0.14 −0.54±0.07
LMFF 1.43 1.96±0.17 3.05±0.16
LMFL 1.09 0.39±0.16 1.99±0.15
LMIF 0.69 1.35±0.13 1.59±0.13
LMIL 0.06±0.15 0.80±0.06
LLVF 0.74 −0.36±0.28 0.52±0.14
LLVL −0.93±0.20 0.22±0.17
LLFF 1.51 1.95±0.36 3.17±0.51
LLFL 0.62±0.18 1.73±0.30
LLIF 1.04±0.15 1.63±0.23
LLIL −0.01±0.12 0.85±0.15
FMVF 0.40 1.14±0.27 1.05±0.16
FMVL -0.03 −1.77±0.17 −0.70±0.22
FMFF 1.41±0.16 2.45±0.15
FMFL −0.74±0.15 0.45±0.27
FMIF 0.82 1.54±0.10 1.94±0.28
FMIL −0.95±0.12 0.33±0.29
FLVF 0.71 0.04±0.18 0.80±0.14
FLVL 0.21 −1.96±0.28 −0.88±0.25
FLFF 1.73±0.39 3.12±0.09
FLFL −0.91±0.08 0.25±0.38
FLIF 1.15 0.61±0.17 1.77±0.21
FLIL 0.54 −1.40±0.19 −0.45±0.48
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Table S7: 5 Site System Folding Free Energies - Part 1
AA Experiment FSWITCH PME
LALVF 0.00 0.00±0.23 0.00±0.16
LALVL -0.20 −1.02±0.12 −0.69±0.11
LALIF 0.40±0.27 −0.18±0.23
LALIL −0.45±0.14 −0.79±0.13
LAAVF 5.04±0.36 5.50±0.61
LAAVL 3.72±0.17 3.44±0.35
LAAIF 5.14±0.70 3.96±0.44
LAAIL 3.86±0.21 3.07±0.31
LAMVF 0.07±0.29 −0.11±0.20
LAMVL −0.90±0.18 −0.07±0.14
LAMIF 0.32±0.18 −0.29±0.17
LAMIL −0.44±0.14 −0.36±0.10
LAVVF 4.57±nana 3.53±nana
LAVVL 2.37±0.16 2.58±0.17
LAVIF 5.41±0.34 3.17±0.12
LAVIL 2.90±0.17 2.44±0.33
LLLVF 0.45±0.39 0.94±0.18
LLLVL 0.55±0.13 0.81±0.26
LLLIF 0.97±0.20 0.43±0.17
LLLIL 1.15±0.15 0.92±0.27
LLAVF 4.91±0.29 5.79±nana
LLAVL 5.31±0.40 4.77±0.36
LLAIF 5.16±nana 4.81±0.31
LLAIL 4.39±nana 4.24±0.42
LLMVF 1.08±0.46 0.14±0.32
LLMVL 0.37±0.26 0.89±0.14
LLMIF 0.33±0.22 0.37±0.23
LLMIL 0.44±0.23 0.98±0.22
LLVVF 3.75±0.69 3.89±0.30
LLVVL 3.83±0.21 3.77±nana
LLVIF 3.23±0.43 2.69±0.18
LLVIL 4.02±0.48 2.81±0.30
LMLVF 1.20±0.19 0.92±0.18
LMLVL −0.09±0.16 −0.19±0.23
LMLIF 1.32±0.14 0.75±0.18
LMLIL 0.40±0.18 −0.20±0.20
LMAVF 3.95±0.39 2.97±0.46
LMAVL 3.69±0.23 3.22±0.17
LMAIF 4.51±0.47 3.01±0.19
LMAIL 4.11±0.22 3.29±0.21
LMMVF 0.79±0.27 0.39±0.21
LMMVL −0.84±0.13 −0.08±0.17
LMMIF 0.73±0.17 0.49±0.19
LMMIL −0.55±0.21 −0.35±0.21
LMVVF 3.53±0.20 2.61±0.25
LMVVL 3.00±0.20 2.54±0.23
LMVIF 3.29±0.43 2.45±0.26
LMVIL 2.99±0.17 2.39±0.35
LVLVF 0.43±0.26 0.54±0.19
LVLVL 0.01±0.14 0.12±0.08
LVLIF 1.10±0.22 0.07±0.21
LVLIL 0.47±0.10 0.30±0.07
LVAVF 8.04±nana 5.16±0.58
LVAVL 4.87±0.28 4.21±0.19
LVAIF in f b±nana 3.97±0.48
LVAIL 4.87±0.72 4.21±0.52
LVMVF 0.26±0.35 0.45±0.30
LVMVL −0.47±0.15 0.12±0.14
LVMIF 1.06±0.20 0.62±0.23
LVMIL 0.02±0.13 0.34±0.10
LVVVF 5.60±0.38 4.06±0.70
LVVVL 3.03±0.19 2.93±0.18
LVVIF 5.28±nana 3.26±0.18
LVVIL 3.69±0.28 3.19±0.18
LWLVF 2.20 4.03±0.30 4.03±0.21
LWLVL 4.42±0.58 3.27±0.26
LWLIF 4.38±0.58 2.84±0.53
LWLIL 6.09±0.83 3.34±0.41
LWAVF 4.09±0.27 3.92±0.24
LWAVL 4.20±0.25 4.11±0.26
LWAIF 4.41±0.20 3.72±0.10
LWAIL 4.41±0.28 3.90±0.14
LWMVF 2.07±0.16 1.47±0.22
LWMVL 1.95±0.11 2.06±0.15
LWMIF 1.88±0.33 1.30±0.15
LWMIL 1.99±0.16 1.54±0.33
LWVVF 4.73±0.15 3.64±0.18
LWVVL 4.67±0.15 3.97±0.22
LWVIF 4.38±0.24 3.22±0.11
LWVIL 4.90±0.18 3.59±0.14
aInsufficient sampling to estimate uncertainty
bSequence not sampled
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Table S8: 5 Site System Folding Free Energies - Part 2
AA Experiment FSWITCH PME
AALVF 2.70 1.71±0.27 1.08±0.41
AALVL 2.54±0.19 2.35±0.19
AALIF 2.48±0.19 1.60±0.47
AALIL 3.05±0.18 2.35±0.24
AAAVF 6.08±nana 4.22±nana
AAAVL 7.54±nana 4.94±0.45
AAAIF in f b±nana 4.41±nana
AAAIL in f b±nana 5.14±0.81
AAMVF 1.76±0.56 1.47±0.50
AAMVL 3.65±0.22 2.85±0.47
AAMIF 3.14±0.37 1.56±0.64
AAMIL 3.13±0.65 3.12±0.22
AAVVF 4.34±0.24 3.83±0.69
AAVVL 5.53±0.47 4.83±nana
AAVIF 5.98±nana 3.73±0.78
AAVIL 6.59±0.62 4.46±nana
ALLVF 0.65±0.20 1.57±0.18
ALLVL 0.36±0.13 0.93±0.13
ALLIF 1.72±0.21 1.52±0.20
ALLIL 0.89±0.17 1.06±0.20
ALAVF 6.11±0.57 7.08±nana
ALAVL 4.72±0.51 4.51±0.23
ALAIF in f b±nana 5.35±0.17
ALAIL 5.09±0.64 4.34±0.23
ALMVF 0.71±0.23 1.58±0.21
ALMVL 0.09±0.21 1.33±0.15
ALMIF 1.61±0.31 1.62±0.27
ALMIL 0.77±0.41 1.34±0.12
ALVVF 4.95±0.44 5.68±0.42
ALVVL 3.33±0.10 4.07±0.31
ALVIF 5.17±0.22 4.01±0.15
ALVIL 3.81±0.50 3.96±0.28
AMLVF 1.38±0.22 1.58±0.20
AMLVL 1.10 1.26±0.16 1.37±0.15
AMLIF 1.40 2.01±0.09 1.20±0.18
AMLIL 1.85±0.17 1.50±0.14
AMAVF 5.04±0.55 4.36±0.48
AMAVL 5.35±0.14 4.32±0.18
AMAIF 5.82±0.33 4.15±0.51
AMAIL 4.57±0.73 4.13±0.35
AMMVF 0.69±0.20 1.70±0.17
AMMVL 0.77±0.10 1.10±0.17
AMMIF 1.46±0.18 1.53±0.14
AMMIL 0.81±0.20 1.34±0.25
AMVVF 4.04±0.20 4.14±0.19
AMVVL 4.15±0.21 3.63±0.28
AMVIF 4.84±0.25 3.56±0.25
AMVIL 4.08±0.19 3.44±0.72
AVLVF 2.00±0.12 2.04±0.13
AVLVL 1.40±0.10 1.97±0.10
AVLIF 2.48±0.38 2.47±0.12
AVLIL 2.00±0.15 1.97±0.07
AVAVF 5.96±nana 4.77±1.16
AVAVL 3.50 4.65±0.94 5.40±0.21
AVAIF in f b±nana 5.93±0.36
AVAIL 6.69±0.71 5.42±0.54
AVMVF 1.29±0.32 1.91±0.24
AVMVL 2.30 1.07±0.15 1.70±0.10
AVMIF 2.40±0.39 1.89±0.11
AVMIL 1.78±0.21 1.98±0.11
AVVVF 4.65±0.37 4.38±0.32
AVVVL 4.46±0.10 4.42±0.26
AVVIF 5.92±0.63 5.23±0.45
AVVIL 4.85±0.28 4.70±0.30
AWLVF 4.38±0.24 4.34±0.21
AWLVL 5.83±nana 4.87±0.31
AWLIF 5.31±0.28 4.11±0.17
AWLIL 6.29±nana 5.37±0.30
AWAVF 4.63±1.04 6.11±0.15
AWAVL 6.30±1.03 7.51±0.55
AWAIF 6.04±0.74 6.18±0.20
AWAIL 6.37±0.39 6.67±0.62
AWMVF 2.26±0.09 2.27±0.44
AWMVL 4.42±0.21 5.18±0.42
AWMIF 2.51±0.17 2.12±0.36
AWMIL 4.25±0.55 4.22±0.61
AWVVF 5.35±0.18 4.77±0.35
AWVVL 7.00±0.25 6.30±0.44
AWVIF 5.73±0.16 4.93±0.21
AWVIL 7.34±0.40 6.10±0.89
aInsufficient sampling to estimate uncertainty
bSequence not sampled
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Table S9: 5 Site System Folding Free Energies - Part 3
AA Experiment FSWITCH PME
IALVF 2.68±0.22 2.44±0.34
IALVL 1.32±0.13 1.68±0.15
IALIF 3.71±0.34 2.83±0.25
IALIL 2.01±0.21 1.80±0.16
IAAVF 7.65±nana in f b±nana
IAAVL 6.03±0.35 4.96±0.44
IAAIF 9.11±nana 6.35±0.25
IAAIL 6.48±0.54 4.88±0.27
IAMVF 3.00±0.27 3.06±0.27
IAMVL 1.64±0.30 2.74±0.16
IAMIF 2.86±0.90 2.06±0.28
IAMIL 1.96±0.23 2.24±0.21
IAVVF 5.84±0.39 4.80±nana
IAVVL 4.88±0.35 3.12±0.78
IAVIF 6.08±nana 4.41±0.50
IAVIL 5.51±0.27 3.22±0.59
ILLVF 1.69±0.21 2.19±0.17
ILLVL 0.84±0.12 1.82±0.18
ILLIF 2.17±0.35 2.12±0.21
ILLIL 1.53±0.14 1.76±0.17
ILAVF 6.04±0.67 5.93±0.27
ILAVL 4.27±0.29 5.29±0.29
ILAIF 5.19±0.76 5.04±0.34
ILAIL 5.15±0.41 5.25±0.38
ILMVF 1.10±0.20 2.34±0.14
ILMVL 0.23±0.30 1.79±0.29
ILMIF 1.35±0.33 1.82±0.25
ILMIL 1.06±0.29 2.12±0.18
ILVVF 3.93±0.24 4.44±0.17
ILVVL 3.13±0.30 3.62±0.19
ILVIF 3.58±0.42 3.99±0.21
ILVIL 3.96±0.24 3.57±0.27
IMLVF 2.65±0.21 3.41±0.28
IMLVL 1.18±0.17 1.34±0.08
IMLIF 2.45±0.58 2.66±0.16
IMLIL 1.79±0.18 1.47±0.14
IMAVF 6.29±nana 5.85±0.26
IMAVL 4.53±0.37 4.57±0.30
IMAIF 6.75±nana 5.26±0.21
IMAIL 6.12±0.24 4.78±0.17
IMMVF 1.65±0.17 2.47±0.21
IMMVL 0.50±0.17 1.43±0.12
IMMIF 2.11±0.20 2.00±0.13
IMMIL 1.05±0.31 1.39±0.14
IMVVF 4.49±0.32 4.71±0.35
IMVVL 3.94±0.15 3.51±0.38
IMVIF 5.47±0.41 4.66±0.17
IMVIL 4.70±0.35 3.49±0.32
IVLVF 2.62±0.45 2.79±0.19
IVLVL 1.15±0.10 1.80±0.09
IVLIF 4.13±0.27 2.54±0.10
IVLIL 1.82±0.16 1.81±0.12
IVAVF 5.94±nana in f b±nana
IVAVL 5.16±0.35 5.33±0.19
IVAIF 8.16±nana 6.64±nana
IVAIL 6.42±0.53 5.36±0.21
IVMVF 1.79±0.57 2.58±0.15
IVMVL 0.68±0.14 1.75±0.16
IVMIF 3.06±0.37 2.52±0.20
IVMIL 1.55±0.17 1.85±0.17
IVVVF 4.80±0.45 5.40±0.31
IVVVL 3.88±0.42 4.62±0.24
IVVIF 6.41±0.32 4.93±0.18
IVVIL 4.79±0.17 4.00±0.27
IWLVF 5.32±0.34 4.76±0.60
IWLVL 4.67±0.84 5.80±nana
IWLIF 5.63±0.32 4.60±0.37
IWLIL 6.41±0.56 5.86±0.63
IWAVF 5.83±0.23 5.71±0.16
IWAVL 5.89±0.21 6.57±0.12
IWAIF 5.38±0.41 5.32±0.15
IWAIL 6.26±0.27 5.76±0.20
IWMVF 1.40 2.74±0.22 2.94±0.23
IWMVL 3.09±0.16 4.31±0.18
IWMIF 3.19±0.17 2.79±0.20
IWMIL 3.59±0.28 4.04±0.17
IWVVF 5.67±0.22 5.13±0.22
IWVVL 5.73±0.20 5.68±0.21
IWVIF 5.82±0.21 5.00±0.17
IWVIL 6.28±0.16 5.37±0.20
aInsufficient sampling to estimate uncertainty
bSequence not sampled
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Table S10: 3 Site System Folding Free Energies - SSλD
AA Experiment FSWITCH PME
IIL 0.00 0.00±0.00 0.00±0.00
MIL 2.20 0.94±0.15 0.97±0.10
IML 3.10 3.95±0.10 3.77±0.07
IIM 2.00 2.97±0.02 2.40±0.12
Table S11: 4 Site System Folding Free Energies - SSλD
AA Experiment FSWITCH PME
LMVF 0.00 0.00±0.00 0.00±0.00
FMVF 0.40 0.35±0.09 0.27±0.12
LLVF 0.74 −0.60±0.09 0.24±0.20
LMFF 1.43 2.73±0.40 2.62±0.19
LMIF 0.69 1.29±0.42 1.12±0.21
LMVL -0.20 −1.30±0.09 −0.76±0.12
Table S12: 5 Site System Folding Free Energies - SSλD
AA Experiment FSWITCH PME
LALVF 0.00 0.00±0.00 0.00±0.00
AALVF 2.70 2.00±0.23 2.06±nana
IALVF 3.15±0.14 2.92±0.28
LLLVF −0.99±0.32 0.41±0.29
LMLVF 0.36±0.27 1.37±0.35
LVLVF −0.27±0.26 0.60±0.33
LWLVF 2.20 3.37±0.24 4.05±nana
LAAVF 5.01±0.32 4.61±0.14
LAMVF 0.01±0.13 −0.00±0.10
LAVVF 4.63±0.13 3.94±0.22
LALIF 0.45±0.10 −0.21±0.07
LALVL -0.20 −1.30±0.09 −0.76±0.12
aInsufficient sampling to estimate uncertainty
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Charles L. Brooks III 
Cyrus Levinthal Distinguished University Professor  
   of Chemistry and Biophysics 
Warner-Lambert/Parke-Davis Professor  
  of Chemistry 
Professor of Biophysics 
Professor of Chemistry 
Chair of Biophysics 
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Referee(s)' Comments to Author: 
 
Reviewer 1 
 
Comments to the Author 
This is a high quality paper that is easy to referee. Lambda-dynamics is extended to the protein design 
problem of computing stabilities for a large library of lysozyme sequences, which differ at a few positions. 
Lambda-dynamics has improved over the years in important ways and it provides here accurate folding 
free energy differences for 240 lysozyme sequences using a single MD simulation. This is at the lower 
limit of bona fide protein design problems but the method has the obvious potential to scale further. The 
method opens new possibilities for protein design, providing high-accuracy, medium-throughput 
simulations that can be applied to a problem eg after a first, very high-throughput pass has been done 
with a less accurate design tool. Overall, the methodology is very original and important. The quality of 
the data and the discussion are high. The presentation is clear and complete. The paper is very well-
suited to Protein Science. 
 
Thanks for a favorable review. Your explanation of potential use cases is quite insightful. 
 
Reviewer 2 
 
Comments to the Author 
This manuscript reports on the performance of a computational method for computing free energy 
differences known as multisite λ dynamics.  Application is to predicting changes in protein stability upon 
mutation of side chains in T4 lysozyme, for which there is a wealth of data.   A major advantage of MSλD 
is the need for only simulating the ends states and that the free energy can be computed for multiple 
sequences simultaneously.  This allows the search of a much larger sequence space than possible with 
FEP, which is restricted to one site at a time and several intermediate simulations between the end states 
are needed.  The multisite results are encouraging and a nice general discussion of the value of MSλD 
for protein design is presented. On the other hand, the Methods and Supplementary sections are highly 
technical and directed to someone already intimately familiar with MSλD.  Nevertheless, because the 
methodology is directed toward protein design, and the results indicate accurate free energy differences 
can be obtained, the paper should be of interest to the general audience of Protein Science if the following 
points can be addressed in a revised ms.  
A. The multiple site calculations are of most interest but some additional explanation is needed for how 
the calculation is done and what is the outcome.  The results in Fig 2 are a major part of the work being 
reported, so that clarifying the points below would help the reader understand these results. 
1. The sentence on p. 8 “The 3 site, 4 site and 5 site systems comprised 8, 24, and 240 sequences 
with 6, 14, and 9 experimental measurements at the same pH” needs to be explained. The 8, 24 
and 240 is some combination of the mutants listed in table 3 but it’s not clear how the number of 
sequences is determined. And, how is this very large number of sequences (8+24+240) 
connected to the much smaller number of experimental measurements (6+14+9)?  The basis for 
these numbers needs to be spelled out a bit more. 
 
We added more details to the introduction of these numbers on page 8, and note that we only 
compare the experimentally measured sequences with experiment. 
 
2. What are the experimental data plotted in Figure 2 in the case of multisite mutations?  The 
table in ref 49 with experimental data shows single mutation free energy changes.  Double 
mutants are typically not the sum of single mutants, so what is compared for multisite FE 
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differences?  Are the MSλD results somehow using FE values for only single sites relative to WT?  
Further, the figure is labeled “All multisite mutants” yet the description quoted above in #1 gives 
8+24+240 sequences, which clearly is not the number of values plotted in figure 2.  So what is 
meant by “all multisite mutants”? 
 
While most of the mutations in ref 49 are point mutants, several dozen are multisite mutants. We 
have modified the text to mention we only compare with the experimentally measured sequences. 
We also changed the titles of the figures from “all multisite mutants” to “all multisite systems”. 
 
3. How are the sites treated in a multisite MSλD run?  It is my understanding that all targeted sites 
are scaled in a multidimensional λ space in a single run.  If one residue has two or more 
substitutions (e.g. V111 in Table 3), are all of the amino acid types mutated in one run?  How are 
the interactions handled between residues of different sites? For example, do mutants at residue 
99 interact with mutants at residue 102 in the 4 site system? 
 
We modified the single site section to mention all mutations at a site are present in the same 
simulation, and added the sentence “Interactions between side chains at different sites are scaled 
by the product of their λ variables, so mutating side chains at two sites only interact when they 
are both on, which allows MSλD to explicitly account for coupling between sites,” to the multisite 
section to address this confusion. So the answer to your question is yes, whichever side chain is 
on (with nonzero λ) at residue 99 will interact with whichever side chain is on at site 102.  
 
4. What is set to zero in Figure 1 and 2?  Presumably it is WT but it is not specified in the caption. 
 
We added the phrase “free energies are plotted relative to wild type with C54T/C97A” to both 
captions. 
 
5. How is convergence assessed for the MSλD results?  Is there some measure of in terms of the 
evolution of λ? 
 
Convergence is typically assessed through the statistical uncertainty in the 5 duplicate runs. Table 
S2 in the Supporting Information shows the lack of convergence that can occur if optimal biasing 
potentials are not used. Convergence is also touched on in Figure 3c since SSλD simulations 
should be more converged than MSλD simulations because fewer sequences need to be 
sampled. Temporal convergence is beyond the scope of this article, but we ran 20 to 40 ns 
because this is in the ballpark of what is conventional with MSλD (10 to 30 ns in recent 
publications).  
 
B. The point that MSλD is more efficient than FEP is made repeatedly and argued in a descriptive manner 
with statements about the number of simulations for FEP vs MSλD, etc.  The efficiency of MSλD makes 
sense, but could a more quantitative comparison be given, such as a rough estimate of the relative CPU 
time required for a large scale study using FEP compared to using MSλD? 
 
No, a more quantitative comparison cannot be given without expending a lot of computer time. In another 
study of drug binding, we ran FEP on a small subset, roughly 7%, of the ligands studied with MSλD, but 
the FEP simulations took more time than the MSλD simulations. In that study a difference of a factor of 
20-30 was estimated. The central issue is that one has to obtain free energy estimates of comparable 
precision on the same system, as some systems (e.g. small to large vs. large to small mutations in 
proteins) converge at different rates. We ran our simulations for roughly the same amount of time as 
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standard FEP simulations, but obtained far better precision and accuracy. Running long enough FEP 
simulations to obtain that level of precision would be intractable. We added a long discussion to the SI 
and mention it in the main text. 
 
C. The authors should make some kind of comparison between the mutant structures from MSλD with 
the crystal structures.  In particular, there are structural changes noted in ref 49 associated with the L99A 
cavity.  Such a comparison would be useful, particularly given that the authors speculate that relaxation 
of the structure influences their results. 
 
This was the most difficult and most fruitful suggestion. We have added 3 pages to the SI and two 
paragraphs and a figure to the main text discussing structural relaxation in the context of solved 
structures. Ironically, the structural relaxations for L99 are quite rapid, but this is not the case for several 
of the other sites. 
 
Some minor points on the written presentation are the following: 
1. P. 5: “C54T/C97A background” should be defined 
 
Done 
 
2. Footnote to Table 2 is a squared quantity but the values are labeled root mean squared 
 
Thanks, we have corrected the equation in tables 2 and 4 
 
3. P. 10 last paragraph: “5/2 sequences” and “23/13 sequences.”  What is the slash? 
 
The slash denotes either FSWITCH or PME simulations. We have reworded the sentence to clarify. 
 
4. P. 15 The first paragraph of section Prospects of MSλD for Protein Design is not clear.  Suggest 
rewriting. 
 
We have rewritten this section to clarify the difference between state-of-the-art protein design methods 
which are generative, and the FEP approach which is currently only accurate enough to perturb existing 
sequences. 
 
5. P. 21-22 bottom.  One sentence states only side chain dihedrals are scaled, yet there is discussion 
about phi and psi angles also being scaled.  Please clarify. 
 
Some dihedrals including Cb involve the same rotatable bond as the f and y angles. We have clarified 
this point in the text. 
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